Literature DB >> 12015456

The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection.

Riana Cockeran1, Ronald Anderson, Charles Feldman.   

Abstract

In addition to being cytotoxic for eukaryotic cells, recent research has clearly indicated that pneumolysin at sub-cytolytic concentrations potentiates the proinflammatory activities of neutrophils and macrophages. Together these cytotoxic and proinflammatory activities of the toxin are likely to contribute to the virulence of the pneumococcus, particularly in facilitating adherence, invasion and dissemination of this important microbial pathogen. Pneumolysin-based vaccine strategies, although in the early stages of development and evaluation, show promise in reducing the severity of pneumococcal disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12015456     DOI: 10.1097/00001432-200206000-00004

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  18 in total

Review 1.  ppGpp conjures bacterial virulence.

Authors:  Zachary D Dalebroux; Sarah L Svensson; Erin C Gaynor; Michele S Swanson
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

2.  Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.

Authors:  Lea-Ann S Kirkham; Johanna M C Jefferies; Alison R Kerr; Yu Jing; Stuart C Clarke; Andrew Smith; Tim J Mitchell
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

3.  Activation-dependent modulation of Streptococcus pneumoniae-mediated death in human lymphocytes.

Authors:  Kristina M Grayson; Lance K Blevins; Melissa B Oliver; David A Ornelles; W Edward Swords; Martha A Alexander-Miller
Journal:  Pathog Dis       Date:  2017-03-01       Impact factor: 3.166

Review 4.  Streptococcus adherence and colonization.

Authors:  Angela H Nobbs; Richard J Lamont; Howard F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

5.  Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury.

Authors:  Danielle Salha; Jason Szeto; Lisa Myers; Carol Claus; Anthony Sheung; Mei Tang; Belma Ljutic; David Hanwell; Karen Ogilvie; Marin Ming; Benjamin Messham; Germie van den Dobbelsteen; Robert Hopfer; Martina M Ochs; Scott Gallichan
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

6.  Microarray analysis of pneumococcal gene expression during invasive disease.

Authors:  Carlos J Orihuela; Jana N Radin; Jack E Sublett; Geli Gao; Deepak Kaushal; Elaine I Tuomanen
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

7.  Differences in clinical manifestation of Streptococcus pneumoniae infection are not correlated with in vitro production and release of the virulence factors pneumolysin and lipoteichoic and teichoic acids.

Authors:  Annette Spreer; Astrid Lis; Joachim Gerber; Ralf René Reinert; Helmut Eiffert; Roland Nau
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Invasion of porcine brain microvascular endothelial cells by Streptococcus suis serotype 2.

Authors:  Ghyslaine Vanier; Mariela Segura; Peter Friedl; Sonia Lacouture; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 9.  Hijacking and Use of Host Lipids by Intracellular Pathogens.

Authors:  Alvaro Toledo; Jorge L Benach
Journal:  Microbiol Spectr       Date:  2015-12

10.  Nontypeable Haemophilus influenzae inhibits autolysis and fratricide of Streptococcus pneumoniae in vitro.

Authors:  Wenzhou Hong; Pawjai Khampang; Christy Erbe; Suresh Kumar; Steve R Taylor; Joseph E Kerschner
Journal:  Microbes Infect       Date:  2013-11-21       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.